FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Case sensitive SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym Active Case sensitive SNOMED CT model component

131244 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set Is a Historical association true Inferred relationship Some
Members associationTargetComponent
adrenaline (epinephrine) 300 microgram/0.3 mL injection, 2 x 1 dose adrenaline (epinephrine) 300 microgram/0.3 mL injection, 2 x 0.3 mL pen devices
adrenaline (epinephrine) 300 microgram/0.3 mL injection, dose adrenaline (epinephrine) 300 microgram/0.3 mL injection, pen device
epinephrine 500 microgram / 0.3 mL injection, 0.3 mL injection device (medicinal product unit of use) Unknown Cell Type 2
adrenaline (epinephrine) 500 microgram/0.3 mL injection, 1 dose adrenaline (epinephrine) 500 microgram/0.3 mL injection, 0.3 mL pen device
epinephrine 500 microgram / 0.3 mL injection, 1 x 0.3 mL injection device (medicinal product pack) Unknown Cell Type 2
adrenaline (epinephrine) 500 microgram/0.3 mL injection, dose adrenaline (epinephrine) 500 microgram/0.3 mL injection, pen device
lidocaine (lignocaine) hydrochloride 4% + tetracaine (amethocaine) hydrochloride 0.5% + adrenaline (epinephrine) acid tartrate 0.18% solution, 5 mL vial adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, vial
lidocaine (lignocaine) hydrochloride 4% + tetracaine (amethocaine) hydrochloride 0.5% + adrenaline (epinephrine) acid tartrate 0.18% solution, 5 x 5 mL vials adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride monohydrate 4.24% solution, 5 x 5 mL vials
adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine (lignocaine) hydrochloride monohydrate 4.25% gel, vial adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial
adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine (lignocaine) hydrochloride monohydrate 4.25% gel, 5 x 4 mL vials adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, 5 x 4 mL vials
epoetin beta 100 microgram/0.3 mL injection, syringe methoxy polyethylene glycol-epoetin beta 100 microgram/0.3 mL injection, syringe
epoetin beta 100 microgram/0.3 mL injection, 0.3 mL syringe methoxy polyethylene glycol-epoetin beta 100 microgram/0.3 mL injection, 0.3 mL syringe
epoetin beta 120 microgram/0.3 mL injection, syringe methoxy polyethylene glycol-epoetin beta 120 microgram/0.3 mL injection, syringe
epoetin beta 120 microgram/0.3 mL injection, 0.3 mL syringe methoxy polyethylene glycol-epoetin beta 120 microgram/0.3 mL injection, 0.3 mL syringe
epoetin beta 200 microgram/0.3 mL injection, syringe methoxy polyethylene glycol-epoetin beta 200 microgram/0.3 mL injection, syringe
epoetin beta 200 microgram/0.3 mL injection, 0.3 mL syringe methoxy polyethylene glycol-epoetin beta 200 microgram/0.3 mL injection, 0.3 mL syringe
epoetin beta 30 microgram/0.3 mL injection, syringe methoxy polyethylene glycol-epoetin beta 30 microgram/0.3 mL injection, syringe
epoetin beta 30 microgram/0.3 mL injection, 0.3 mL syringe methoxy polyethylene glycol-epoetin beta 30 microgram/0.3 mL injection, 0.3 mL syringe
epoetin beta 360 microgram/0.6 mL injection, syringe methoxy polyethylene glycol-epoetin beta 360 microgram/0.6 mL injection, syringe
epoetin beta 360 microgram/0.6 mL injection, 0.6 mL syringe methoxy polyethylene glycol-epoetin beta 360 microgram/0.6 mL injection, 0.6 mL syringe
epoetin beta 50 microgram/0.3 mL injection, syringe methoxy polyethylene glycol-epoetin beta 50 microgram/0.3 mL injection, syringe
epoetin beta 50 microgram/0.3 mL injection, 0.3 mL syringe methoxy polyethylene glycol-epoetin beta 50 microgram/0.3 mL injection, 0.3 mL syringe
epoetin beta 75 microgram/0.3 mL injection, syringe methoxy polyethylene glycol-epoetin beta 75 microgram/0.3 mL injection, syringe
epoetin beta 75 microgram/0.3 mL injection, 0.3 mL syringe methoxy polyethylene glycol-epoetin beta 75 microgram/0.3 mL injection, 0.3 mL syringe
erythromycin (as lactobionate) 1 g injection, vial erythromycin 1 g injection, vial
erythromycin (as lactobionate) 1 g injection, 1 vial erythromycin 1 g injection, 1 vial
erythromycin (as lactobionate) 1 g injection, 10 vials erythromycin 1 g injection, 10 vials
erythromycin 1 g injection, vial erythromycin 1 g injection, vial
erythromycin 1 g injection, 1 vial erythromycin 1 g injection, 1 vial
erythromycin lactobionate erythromycin
etanercept 50 mg / 1 mL injection, 1 mL injection device (medicinal product unit of use) Unknown Cell Type 2
etanercept 50 mg / 1 mL injection, 1 x 1 mL injection device (medicinal product pack) Unknown Cell Type 2
etanercept 50 mg / 1 mL injection, 12 x 1 mL injection devices (medicinal product pack) Unknown Cell Type 2
etanercept 50 mg / 1 mL injection, 2 x 1 mL injection devices (medicinal product pack) Unknown Cell Type 2
etanercept 50 mg / 1 mL injection, 4 x 1 mL injection devices (medicinal product pack) Unknown Cell Type 2
etanercept 50 mg/mL injection, 1 mL injection device Unknown Cell Type 2
etanercept 50 mg/mL injection, 12 x 1 mL injection devices Unknown Cell Type 2
etanercept 50 mg/mL injection, 2 x 1 mL injection devices Unknown Cell Type 2
etanercept 50 mg/mL injection, 4 x 1 mL injection devices Unknown Cell Type 2
etanercept 50 mg/mL injection, injection device Unknown Cell Type 2
methyl salicylate + ethanol methyl salicylate
ethanol 0.4 mL / 1 g + glycerol 200 mg / 1 g + lidocaine 5 mg / 1 g + menthol 500 microgram / 1 g + salicylic acid 20 mg / 1 g + tannic acid 5 mg / 1 g + thymol 500 microgram / 1 g oral gel (medicinal product unit of use) Unknown Cell Type 2
ethanol 0.4 mL / 1 g + glycerol 200 mg / 1 g + lidocaine 5 mg / 1 g + menthol 500 microgram / 1 g + salicylic acid 20 mg / 1 g + tannic acid 5 mg / 1 g + thymol 500 microgram / 1 g oral gel, 10 g (medicinal product pack) Unknown Cell Type 2
potassium iodide 1% + iodine 1% + ethanol 70% application potassium iodide 1% + iodine 1% + ethanol 70% solution
potassium iodide 1% + iodine 1% + ethanol 70% application, 100 mL potassium iodide 1% + iodine 1% + ethanol 70% solution, 100 mL
potassium iodide 0.5% + iodine 0.5% + ethanol 70% application potassium iodide 0.5% + iodine 0.5% + ethanol 70% solution
potassium iodide 0.5% + iodine 0.5% + ethanol 70% application, 100 mL potassium iodide 0.5% + iodine 0.5% + ethanol 70% solution, 100 mL
methyl salicylate 0.5% + ethanol 95% solution methyl salicylate 0.5% solution
methyl salicylate 0.5% + ethanol 95% solution, 100 mL methyl salicylate 0.5% solution, 100 mL
ethanol 96% + methyl salicylate 0.5% solution methyl salicylate 0.5% solution
ethanol 96% + methyl salicylate 0.5% solution, 100 mL methyl salicylate 0.5% solution, 100 mL
ethanol 40% + glycerol 20% + lidocaine (lignocaine) 0.5% + menthol 0.05% + salicylic acid 2% + tannic acid 0.5% + thymol 0.05% oral gel Unknown Cell Type 2
ethanol 40% + glycerol 20% + lidocaine (lignocaine) 0.5% + menthol 0.05% + salicylic acid 2% + tannic acid 0.5% + thymol 0.05% oral gel, 10 g Unknown Cell Type 2
ethanol 48.71% gel ethanol 61.5% gel
ethanol 48.71% gel, 125 mL ethanol 61.5% gel, 125 mL
ethanol 48.71% gel, 500 mL ethanol 61.5% gel, 500 mL
ethanol 48.71% gel, 75 mL ethanol 61.5% gel, 75 mL
ethanol 58.73% + iodine 0.1% + triclosan 0.5% application ethanol 58.73% + iodine 0.1% + triclosan 0.5% solution
ethanol 58.73% + iodine 0.1% + triclosan 0.5% application, 125 mL ethanol 58.73% + iodine 0.1% + triclosan 0.5% solution, 125 mL
ethanol 58.73% + iodine 0.1% + triclosan 0.5% application, 500 mL ethanol 58.73% + iodine 0.1% + triclosan 0.5% solution, 500 mL
etoposide 1 g injection, vial etoposide phosphate 1.136 g (etoposide 1 g) injection, vial
etoposide 1 g injection, 1 vial etoposide phosphate 1.136 g (etoposide 1 g) injection, 1 vial
etoposide 100 mg injection, 1 vial etoposide phosphate 113.6 mg (etoposide 100 mg) injection, 1 vial
etoposide 100 mg injection, vial etoposide phosphate 113.6 mg (etoposide 100 mg) injection, vial
etoposide 500 mg injection, 1 x 500 mg vial (medicinal product pack) etoposide phosphate 567.8 mg (etoposide 500 mg) injection, 1 vial
etoposide 500 mg injection, vial etoposide phosphate 567.8 mg (etoposide 500 mg) injection, vial
eucalyptus oil 1 mL/mL liquid eucalyptus oil 1 mL/mL oil
eucalyptus oil 1 mL/mL liquid, 100 mL eucalyptus oil 1 mL/mL oil, 100 mL
eucalyptus oil 1 mL/mL liquid, 105 mL eucalyptus oil 1 mL/mL oil, 105 mL
eucalyptus oil 1 mL/mL liquid, 200 mL eucalyptus oil 1 mL/mL oil, 200 mL
eucalyptus oil 1 mL/mL liquid, 250 mL eucalyptus oil 1 mL/mL oil, 250 mL
eucalyptus oil 1 mL/mL liquid, 50 mL eucalyptus oil 1 mL/mL oil, 50 mL
eucalyptus oil 1 mL/mL liquid, 500 mL eucalyptus oil 1 mL/mL oil, 500 mL
eucalyptus oil 1 mL/mL liquid, 55 mL eucalyptus oil 1 mL/mL oil, 55 mL
evolocumab 140 mg / 1 mL injection, 1 mL injection device (medicinal product unit of use) Unknown Cell Type 2
evolocumab 140 mg / 1 mL injection, 1 x 1 mL injection device (medicinal product pack) Unknown Cell Type 2
evolocumab 140 mg / 1 mL injection, 2 x 1 mL injection devices (medicinal product pack) Unknown Cell Type 2
evolocumab 140 mg / 1 mL injection, 3 x 1 mL injection devices (medicinal product pack) Unknown Cell Type 2
evolocumab 140 mg/mL injection, 1 mL injection device Unknown Cell Type 2
evolocumab 140 mg/mL injection, 2 x 1 mL injection devices Unknown Cell Type 2
evolocumab 140 mg/mL injection, 3 x 1 mL injection devices Unknown Cell Type 2
evolocumab 140 mg/mL injection, injection device Unknown Cell Type 2
exenatide 10 microgram/0.04 mL injection, unit dose exenatide 10 microgram/0.04 mL injection, 2.4 mL pen device
exenatide 10 microgram / 0.04 mL injection, 1 x 2.4 mL injection device (medicinal product pack) Unknown Cell Type 2
exenatide 10 microgram / 0.04 mL injection, 2.4 mL injection device (medicinal product unit of use) Unknown Cell Type 2
exenatide 10 microgram/0.04 mL injection, 60 x 0.04 mL unit doses exenatide 10 microgram/0.04 mL injection, 2.4 mL pen device
exenatide 10 microgram/dose injection, 60 doses exenatide 10 microgram/0.04 mL injection, 2.4 mL pen device
exenatide 10 microgram/dose injection, dose exenatide 10 microgram/0.04 mL injection, 2.4 mL pen device
exenatide 10 microgram/0.04 mL injection, 2.4 mL injection device Unknown Cell Type 2
exenatide 10 microgram/0.04 mL, 2.4 mL injection device Unknown Cell Type 2
exenatide 2 mg/dose + inert substance modified release injection, 1 dual chamber device exenatide 2 mg modified release injection [1 chamber] (&) inert substance diluent [1 chamber], 1 dual chamber pen device
exenatide 2 mg/dose + inert substance modified release injection, 4 dual chamber devices exenatide 2 mg modified release injection [1 chamber] (&) inert substance diluent [1 chamber], 4 dual chamber pen devices
exenatide 2 mg injection [4 vials] (&) inert substance diluent [4 syringes], 1 pack exenatide 2 mg modified release injection [1 vial] (&) inert substance diluent [1 syringe], 4 x 1 packs
exenatide 2 mg injection, vial exenatide 2 mg modified release injection, vial
exenatide 2 mg modified release injection [1 cartridge] (&) inert substance diluent [1 cartridge], 1 pack exenatide 2 mg modified release injection [1 chamber] (&) inert substance diluent [1 chamber], 1 dual chamber pen device
exenatide 2 mg modified release injection [4 cartridges] (&) inert substance diluent [4 cartridges], 1 pack exenatide 2 mg modified release injection [1 chamber] (&) inert substance diluent [1 chamber], 4 dual chamber pen devices
exenatide 5 microgram/0.02 mL injection, unit dose exenatide 5 microgram/0.02 mL injection, 1.2 mL pen device
exenatide 5 microgram / 0.02 mL injection, 1 x 1.2 mL injection device (medicinal product pack) Unknown Cell Type 2
exenatide 5 microgram / 0.02 mL injection, 1.2 mL injection device (medicinal product unit of use) Unknown Cell Type 2
exenatide 5 microgram/0.02 mL injection, 60 x 0.02 mL unit doses exenatide 5 microgram/0.02 mL injection, 1.2 mL pen device
exenatide 5 microgram/dose injection, 60 doses exenatide 5 microgram/0.02 mL injection, 1.2 mL pen device

Start Previous Page 1290 of 1313 Next End

Reference Sets

Australian dialect reference set

Unit of use quantity reference set

Reference set descriptor

Back to Start